Personal information

No personal information available

Activities

Collapse all

Works (9)

Author Correction: Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella

Nature Communications
2025-01-27 | Journal article
DOI: 10.1038/s41467-025-56044-0
Contributors: Dinh-Huy Nguyen; Sung-Hwan You; Hien Thi-Thu Ngo; Khuynh Van Nguyen; Khang Vuong Tran; Tan-Huy Chu; So-young Kim; Sang-Jun Ha; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Tumor Pre-Targeting System Using Streptavidin-Expressing Bacteria

Molecular Imaging and Biology
2024-08 | Journal article
DOI: 10.1007/s11307-024-01915-z
Contributors: Seong-Young Kwon; Sung-Hwan You; Jin Hee Im; Dinh-Huy Nguyen; Dong-Yeon Kim; Ayoung Pyo; Geun-Joong Kim; Hee-Seung Bom; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella

Nature Communications
2024-08-06 | Journal article
DOI: 10.1038/s41467-024-50950-5
Contributors: Dinh-Huy Nguyen; Sung-Hwan You; Hien Thi-Thu Ngo; Khuynh Van Nguyen; Khang Vuong Tran; Tan-Huy Chu; So-young Kim; Sang-Jun Ha; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Reprogramming a Doxycycline-Inducible Gene Switch System for Bacteria-Mediated Cancer Therapy

Molecular Imaging and Biology
2024-02 | Journal article
DOI: 10.1007/s11307-023-01879-6
Contributors: Hien Thi-Thu Ngo; Dinh-Huy Nguyen; Sung-Hwan You; Khuynh Van Nguyen; So-Young Kim; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Reprogramming a doxycycline-inducible gene switch system for bacteria-mediated cancer therapy

2023-09-18 | Preprint
DOI: 10.21203/rs.3.rs-3335399/v1
Contributors: Hien Thi-Thu Ngo; Dinh-Huy Nguyen; Sung-Hwan You; Khuynh Van Nguyen; So-Young Kim; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Bioengineering of bacteria for cancer immunotherapy

Nature Communications
2023-06-15 | Journal article
DOI: 10.1038/s41467-023-39224-8
Contributors: Dinh-Huy Nguyen; Ari Chong; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Optimized Doxycycline-Inducible Gene Expression System for Genetic Programming of Tumor-Targeting Bacteria

Molecular Imaging and Biology
2022-02 | Journal article
DOI: 10.1007/s11307-021-01624-x
Contributors: Dinh-Huy Nguyen; Sung-Hwan You; An-Trang Ngoc Vo; Hien Thi-Thu Ngo; Khuynh Van Nguyen; Mai Thi-Quynh Duong; Hyon E. Choy; Miryoung Song; Yeongjin Hong; Jung-Joon Min
Source: check_circle
Crossref

Pattern of F-18 FDG Uptake in Colon Cancer after Bacterial Cancer Therapy Using Engineered Salmonella Typhimurium: A Preliminary In Vivo Study

Molecular Imaging
2022-01 | Journal article
DOI: 10.1155/2022/9222331
Contributors: Ari Chong; Dinh-Huy Nguyen; Hyeon Sik Kim; June-Key Chung; Jung-Joon Min
Source: check_circle
Crossref

Recent Progress in the Molecular Imaging of Tumor-Treating Bacteria

Nuclear Medicine and Molecular Imaging
2021-02 | Journal article
DOI: 10.1007/s13139-021-00689-4
Contributors: Sae-Ryung Kang; Jung-Joon Min
Source: check_circle
Crossref

Peer review (38 reviews for 20 publications/grants)

Review activity for ACS applied materials & interfaces. (1)
Review activity for ACS chemical biology. (1)
Review activity for ACS medicinal chemistry letters. (1)
Review activity for Advanced materials. (3)
Review activity for Advanced science. (3)
Review activity for Biomaterials. (1)
Review activity for Biomedicine & pharmacotherapy. (1)
Review activity for Cell reports medicine. (2)
Review activity for European journal of nuclear medicine and molecular imaging. (1)
Review activity for European radiology. (1)
Review activity for iScience. (1)
Review activity for Journal of controlled release. (2)
Review activity for Molecular imaging and biology (2)
Review activity for Molecular systems biology. (2)
Review activity for Molecular therapy (3)
Review activity for Nature communications (8)
Review activity for Nature medicine. (1)
Review activity for Nature protocols (1)
Review activity for Signal transduction and targeted therapy. (2)
Review activity for Small. (1)
How many people are using ORCID?